half life of glp-1 agonists glp-1_analogs [TUSOM Approaches for half-life extension of
Description
(2012) 344:d7771
doi: 10.1001/jama.2016.10260
doi: 10.2337/dc20-0720
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
For the gaming side, variety and fairness matter
By enhancing glucose metabolism, they reduce excessive androgen production and can support improved fertility
